Fonte: Ecancermedicalscience. Unidade: FM
Assuntos: COVID-19, NEOPLASIAS, SISTEMA DE SAÚDE, RADIOTERAPIA, PÂNCREAS, ESÔFAGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIECHELMANN, Rachel et al. Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group. Ecancermedicalscience, v. 14, 2020Tradução . . Disponível em: https://doi.org/10.3332/ecancer.2020.1048. Acesso em: 28 out. 2024.APA
Riechelmann, R., Peixoto, R. D. 'A., Fernandes, G. D. S., Weschenfelder, R. F., Prolla, G., Rocha Filho, D., et al. (2020). Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group. Ecancermedicalscience, 14. doi:10.3332/ecancer.2020.1048NLM
Riechelmann R, Peixoto RD'A, Fernandes GDS, Weschenfelder RF, Prolla G, Rocha Filho D, Andrade AC, Crosara M, Rego JFM, Hoff PMG. Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group [Internet]. Ecancermedicalscience. 2020 ; 14[citado 2024 out. 28 ] Available from: https://doi.org/10.3332/ecancer.2020.1048Vancouver
Riechelmann R, Peixoto RD'A, Fernandes GDS, Weschenfelder RF, Prolla G, Rocha Filho D, Andrade AC, Crosara M, Rego JFM, Hoff PMG. Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group [Internet]. Ecancermedicalscience. 2020 ; 14[citado 2024 out. 28 ] Available from: https://doi.org/10.3332/ecancer.2020.1048